Related Experiment Video
Updated: Aug 19, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and
A Paolillo1, C Pozzilli, C Gasperini
1Department of Neurological Sciences, University of Rome 'La Sapienza', Viale dell'Università 30, 00185, Rome, Italy.
Abstract:
Recent MRI studies in multiple sclerosis have highlighted the potential role of brain atrophy evaluation as a putative marker of disease progression. In the present study, we evaluated the supratentorial and infratentorial brain volume in patients with relapsing remitting multiple sclerosis (RR MS) and in healthy subjects. Moreover, we determined whether brain volumes of MS patients are associated with different aspects of brain MRI abnormalities and clinical findings. Two-dimensional acquired MRI was performed on 52 relapsing-remitting multiple sclerosis and 30 healthy subjects. The volume of supratentorial and infratentorial structures was measured in selected representative slices. Gd-enhancement, T2 hyperintense, T1 hypointense (i.e. 'black holes') total lesion load, as well as the area of corpus callosum was calculated in the MS group and related to brain volume measures. Correlations between MRI parameters and clinical features were also considered. MS patients had significantly lower supratentorial, infratentorial brain volume and corpus callosum area than healthy subjects (P<0.01). Supratentorial brain volume was significantly related to corpus callosum area (r=0.58; P<0.01) and T1 hypointense lesion load (r=0.48; P<0.01), but not with T2 hyperintense lesion load. Infratentorial/supratentorial ratio was significantly associated with disease duration and EDSS score (r=-0.34; P=0.02 and r=-0.49; P<0.01, respectively). This study documents that brain atrophy is an early MRI finding in RR MS and it is closely related to 'black holes' burden. The use of relative values (infratentorial/supratentorial ratio) may increase the conspicuity of correlation between clinical and MRI findings.
Insights
Brain atrophy is an early MRI finding in relapsing remitting multiple sclerosis (RR MS). This brain volume reduction correlates with lesion load and disease severity, suggesting its utility as a progression marker.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Brain atrophy is increasingly recognized as a significant indicator of neurological disease progression.
- Multiple Sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system, where brain volume changes are a key concern.
Purpose of the Study:
- To evaluate supratentorial and infratentorial brain volumes in relapsing remitting multiple sclerosis (RR MS) patients compared to healthy controls.
- To investigate the association between brain volumes, MRI-detected abnormalities, and clinical findings in RR MS.
Main Methods:
- Two-dimensional MRI scans were acquired for 52 RR MS patients and 30 healthy subjects.
- Supratentorial and infratentorial brain volumes were measured, alongside lesion load (Gd-enhancement, T2, T1 hypointense 'black holes') and corpus callosum area.
- Correlations between volumetric MRI measures, lesion burden, and clinical data (disease duration, EDSS) were analyzed.
Main Results:
- RR MS patients exhibited significantly reduced supratentorial, infratentorial brain volumes, and corpus callosum area compared to controls (P<0.01).
- Supratentorial volume correlated with corpus callosum area (r=0.58) and T1 hypointense lesions (r=0.48), but not T2 lesions.
- The infratentorial/supratentorial ratio associated with disease duration (r=-0.34) and EDSS score (r=-0.49).
Conclusions:
- Brain atrophy is an early MRI finding in RR MS and is closely linked to the burden of 'black holes' (T1 hypointense lesions).
- Relative brain volume measures, such as the infratentorial/supratentorial ratio, may enhance the detection of correlations between MRI findings and clinical disease progression.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Multiple Sclerosis l: Introduction
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology

